Granzyme B contrast agent-1
Granzyme B contrast agent-1 is a Granzyme B binder with a Kd value of 1.0 nM. When radiolabeled, Granzyme B contrast agent-1 can be used for positron emission tomography (PET) and single-photon emission computed tomography (SPECT) imaging studies of Granzyme B.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3062270-62-3
- Fòrmula: C134H170N26O34S2
- Peso molecular:2753.07
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas Radionuclide-Drug Conjugates (RDCs)
More
Actividad biológica
Descripciòn
IC50 & Target
[1]|
RDC Peptide |
In Vitro
Granzyme B contrast agent-1 (Compound 3a) binds to purified granzyme B with a Kd value of 1.0 nM[1].
Granzyme B contrast agent-1 (0.01-1 μM) binds to purified granzyme B, with an equilibrium dissociation constant (Kd) of 1.1 nM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 3062270-62-3
-
Peso molecular 2753.07
-
Fòrmula C134H170N26O34S2
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Granzyme B contrast agent-1
- 3062270-62-3
- Granzyme B contrast agent1
- Granzyme B contrast agent 1
- Ser/Thr Protease
- Radionuclide-Drug Conjugates (RDCs)
- inflammation
- granzyme B
- cancer immunotherapy
- human granzyme B
- positron emission tomography
- wound healing
- autoimmunity
- PET
- single photon emission tomography
- SPECT
- Inhibitor
- inhibitor
- inhibit